{{Rsnum
|rsid=13398721
|Chromosome=2
|position=19429543
|Orientation=plus
|GMAF=0.3522
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 27.7 | 72.3
| HCB | 48.9 | 46.7 | 4.4
| JPT | 57.8 | 37.8 | 4.4
| YRI | 11.3 | 41.9 | 46.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 48.9 | 46.7 | 4.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23478653
  |Trait=Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
  |Title=A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
  |RiskAllele=
  |Pval=2E-7
  |OR=7.10
  |ORtxt=[3.40-14.70]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}